|
|
Volumn 13, Issue 5, 2007, Pages 623-624
|
|
Autologous Stem Cell Transplantation as Part of First-Line Treatment of Waldenström's Macroglobulinemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
CARMUSTINE;
CHLORAMBUCIL;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
FLUDARABINE;
IMMUNOGLOBULIN M;
MELPHALAN;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
ADULT;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
B LYMPHOCYTE;
CANCER CONTROL;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
DRUG MEGADOSE;
HUMAN;
IMMUNOGLOBULIN BLOOD LEVEL;
LETTER;
LYMPHOCYTE DEPLETION;
MULTIPLE CYCLE TREATMENT;
MYELOABLATIVE CONDITIONING;
SALVAGE THERAPY;
THERAPY EFFECT;
WALDENSTROEM MACROGLOBULINEMIA;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DISEASE-FREE SURVIVAL;
HUMANS;
MIDDLE AGED;
STEM CELL TRANSPLANTATION;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, AUTOLOGOUS;
WALDENSTROM MACROGLOBULINEMIA;
WHOLE-BODY IRRADIATION;
|
|
EID: 34247111279
PISSN: 10838791
EISSN: 15236536
Source Type: Journal
DOI: 10.1016/j.bbmt.2007.01.083 Document Type: Letter |
|
Times cited : (19)
|
|
References (5)
|
